Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | RAF1 | P04049 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7948284 | 0.86 | TDP2 (0.33) | PGRTDP2PRKDC | |
| SCHEMBL12245945 | 0.86 | PGR (0.31) | PGRTDP2PRKDC | |
| SCHEMBL7959910 | 0.82 | KDM4E (0.46) | ALDH1A1GAAKMT2ATDP2RAF1 | |
| SCHEMBL2375582 | 0.73 | BACE1 (0.41) | PGRPRKDC | |
| SCHEMBL2375588 | 0.73 | BACE1 (0.41) | PGRPRKDC | |
| SCHEMBL7965367 | 0.68 | KDM4E (0.46) | ALDH1A1GAAKMT2ARAF1KDM4E | |
| SCHEMBL7959633 | 0.68 | KDM4E (0.33) | ALDH1A1KDM4EHTTATM | |
| SCHEMBL1819491 | 0.67 | KDM4E (0.54) | ALDH1A1GAAKMT2AKDM4EHTT | |
| SCHEMBL30410537 | 0.67 | LMNA (0.36) | HTT | |
| SCHEMBL1822380 | 0.66 | PGR (0.50) | PGRPRKDCRAF1KDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010021680-A2 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, INC. (US) | 2010-02-25 | — | — | WO | disclosed |